Loading...
Please wait, while we are loading the content...
Similar Documents
An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
| Content Provider | Scilit |
|---|---|
| Author | Warren, Richard B. Mrowietz, Ulrich von Kiedrowski, Ralph Niesmann, Johannes Wilsmann-Theis, Dagmar Ghoreschi, Kamran Zschocke, Ina Falk, Thomas M. Blödorn-Schlicht, Norbert Reich, Kristian |
| Copyright Year | 2016 |
| Description | Journal: The Lancet |
| Related Links | https://www.research.manchester.ac.uk/portal/files/46789246/THELANCET_D_16_04293R3.pdf http://thelancet.com/article/S0140673616321274/pdf |
| Ending Page | 537 |
| Page Count | 10 |
| Starting Page | 528 |
| ISSN | 01406736 |
| DOI | 10.1016/s0140-6736%2816%2932127-4 |
| Journal | The Lancet |
| Issue Number | 10068 |
| Volume Number | 389 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2017-02-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: The Lancet General Medicine Randomly Assigned Methotrexate Groups |
| Content Type | Text |
| Resource Type | Article |
| Subject | Medicine |